资讯

Agios Pharmaceuticals: Why A Delayed FDA Review Could Still Be A Positive

Agios awaits a key FDA ruling on mitapivat for thalassemia. Discover investment insights and potential rewards.

SMX and Singapore’s ASTAR Make History By Launching World’s First Plastic Passport ...

NEW YORK, NY / ACCESS Newswire / September 4, 2025 / Governments, companies, and NGOs have long sought ways to make plastic ...